Mon, March 28, 2022
Sun, March 27, 2022
Fri, March 25, 2022
Thu, March 24, 2022
Wed, March 23, 2022
Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022
Wed, March 16, 2022
Tue, March 15, 2022

Carter Gould Maintained (VOR) at Buy with Decreased Target to $26 on, Mar 21st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-26-on-mar-21st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Carter Gould of Barclays, Maintained "Vor Biopharma Inc." (VOR) at Buy with Decreased Target from $56 to $26 on, Mar 21st, 2022.

Carter has made no other calls on VOR in the last 4 months.



There are 4 other peers that have a rating on VOR. Out of the 4 peers that are also analyzing VOR, 0 agree with Carter's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Carter


  • Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $30 on, Wednesday, March 16th, 2022
  • Swayampakula Ramakanth of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $26 on, Friday, December 17th, 2021
  • Jack Allen of "Baird" Initiated at Buy and Held Target at $38 on, Friday, December 3rd, 2021
  • Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $30 on, Thursday, December 2nd, 2021

Publication Contributing Sources